Gamida Cell is a U.S.-focused biotech dedicated to commercializing novel treatments for rare, specialty, and oncology markets with high unmet need. The company currently has two approved products, Omisirge® and APHEXDA®.
ApheresisBiotherapy Processing/SelectionPatient/Donor Identification
